Pharsight

Ocrevus patents expiration

List of large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US7799900 NA Immunoglobulin variants and uses thereof
Oct, 2028

(5 years from now)

Ingredients: OCRELIZUMAB

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic